Protective effects and mechanisms of breviscapine on endothelial cells

Journal of China Pharmaceutical University

Volumn 46, Issue 5, 2015, Pages 610-616

  Chen, Jianping ^a   Ren, Xinsheng ^a   Sun, Zhonghua ^b   Guo, Zaiyu ^a  

^a TIANJIN TEDA HOSPITAL   (China)

^b TEDA INTERNATIONAL CARDIOVASCULAR HOSPITAL   (China)

Author keywords

Breviscapine; Cell apoptosis; Endothelial cells; Reactive oxygen species

Indexed keywords

BREVISCAPINE; CASPASE 3; CYTOCHROME C; GLUTATHIONE TRANSFERASE M1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MTT ASSAY; NUCLEAR IMPORT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TREATMENT DURATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

EID: 84970928344     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lin LL, Liu AJ, Liu S.G., et al. Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats[J]. J Cardiovasc Pharmacol, 2007, 50(3): 327-332.
2. Qi XM, Wu GZ, Wu Y.G., et al. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats [J]. Nephron Exp Nephrol, 2006, 104(4): e147-157.
3. Yan L, Huang H, Tang QZ, et al. Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling[J]. J Cell Biochem, 2010, 109(6): 1158-1171.
4. Wang M, Zhang WB, Zhu J.H., et al. Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway [J]. Acta Pharmacol Sin, 2009, 30(8):1081-1091.
5. Li Q, Wu JH, Guo D.J., et al. Suppression of diet-induced hypercholesterolemia by scutellarin in rats [J]. Planta Med, 2009, 75 (11): 1203-1208.
6. He M, Xue ZM, Li J, et al Breviscapine inhibits high glucoseinduced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathway[J]. Acta Pharmacol Sin, 2012, 33(5): 606-614.
7. Moldovan L, Mythreye K, Goldschmidt-Clermont PJ, et al. Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Racl [J]. Cardiovasc Res, 2006, 71(2): 236-246.
8. Hsieh HJ, Cheng CC, Wu S.T., et al. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression [J]. J Cell Physiol, 1998, 175(2):156-162.
9. Steinberg D, Witztum JL Oxidized low-density lipoprotein and atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2010, 30:2311-2316.
10. Wiesner P, Choi SH, Almazan F, et al Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia[J]. Circ Res, 2010, 107(1): 56-65.
11. Wagner AE, Ernst I, Iori R., et al. Sulforaphane but not ascorbigen, indole-3-carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase-2 and antioxidant enzymes in human keratinocytes in culture[J]. Exp Dermatol, 2010, 19(2): 137-144.
12. Chavakis E, Dernbach E. Hermann C, et al. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway [J]. Circulation, 2001, 103 (16): 2102-2107.
13. Kotamraju S, Hogg N, Joseph J., et al. Inhibition of oxidized lowdensity lipoprotein-induced apoptosis in endothelial cells by nitric oxide. Peroxyl radical scavenging as an antiapoptotic mechanism [J]. J Biol Chem, 2001, 276(20): 17316-17323.
14. Wang Y, Ji M, Chen L., et al. Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18[J]. Exp Ther Med, 2013, 6(5):1322-1326.
15. Zhang H. Cai CZ, Zhang XQ, et al. Breviscapine attenuates acute pancreatitis by inhibiting expression of PKCα and NF-ΚB in pancreas [J]. World J Gastroenterol, 2011, 17(14):1825-1830.
16. Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress [J]. Mol Cell Biol, 2003, 23(22): 8137-8151.
17. Kobayashi Al, Kang MI, Okawa H, et al Oxidative stress sensor Keapl functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2[J]. Mol Cell Biol, 2004, 24 (16):7130-7139.
18. Jain AK, Bloom DA, Jaiswal AK Nuclear import and export signals in control of Nrf2[J]. J Biol Chem, 2005, 280(32): 29158-29168.
19. Dhakshinamoorthy S, Jaiswal AK Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: quinone oxidoreductasel gene[J]. Oncogene, 2001, 20(29): 3906-3917.
20. Hayes JD, Chanas SA, Henderson C.J., et al. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin[J]. Biochem Soc Trans, 2000, 28(2): 33-4L